Hepatitis B: all 1,662 studies
Page 9 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Serum HBV RNA Value on Chronic Hepatitis B Virus Infection ManageCompletedNCT03909191
- Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRCCompletedNCT03897946Phase 4
- Evaluation of an Infant Immunization Encouragement Program in NigeriaCompletedNCT03870061Not applicable
- Hepatitis B Virus Infection in Immunized Children With HBsAg-positive ParentsStatus unknownNCT03864263
- Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV InfectionStatus unknownNCT03854630Phase 4
- Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy VolunteersCompletedNCT03847246Not applicable
- Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in SenegalWithdrawnNCT03829735Not applicable
- Non-vaccination Factors Against Hepatitis B Virus in Drug UsersCompletedNCT03817697
- The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir AlafenamideTerminatedNCT03804372Phase 2
- A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsStatus unknownNCT03801798Phase 2
- The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAgStatus unknownNCT03801538Phase 4
- TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)Status unknownNCT03798119Phase 4
- A Comprehensive HBsAg-positive Patients Centered Screening StrategyCompletedNCT03794791
- Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedNCT03778567Phase 4
- Prediction System of Clinical Endpoint Events for Chronic Hepatitis B PatientsActive, not recruitingNCT03777969
- Study of Safety and Tolerability of DCR HBVSCompletedNCT03772249Phase 1
- A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINAStatus unknownNCT03770624Phase 1
- NK Cell Deregulation in HBV PatientsActive, not recruitingNCT03761875Not applicable
- Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral ActivityStatus unknownNCT03759782Phase 3
- Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current GuidelinesActive, not recruitingNCT03753074Phase 4
- TAF Real World Study for Universal EffectivenessStatus unknownNCT03752658
- Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase LevelsStatus unknownNCT03740789
- IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHBCompletedNCT03734783
- Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT03733652Not applicable
- A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis BCompletedNCT03714152Phase 1
- Hepatocellular Carcinoma in HIV-infected Individuals in Asian PopulationCompletedNCT03702998
- Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B VirusStatus unknownNCT03695029Phase 4
- An Observational Study of Patients With Chronic Hepatitis B (CHB) InfectionTerminatedNCT03692897
- The Norwegian Nucleoside Analogue Stop StudyCompletedNCT03681132Phase 4
- Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)Status unknownNCT03680183
- A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy SubjectsCompletedNCT03662568Phase 1
- Terminator 2 RegisterStatus unknownNCT03643172
- A Post-marketing Surveillance to Assess Safety and Efficacy of BesivoStatus unknownNCT03642340
- The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver FailureStatus unknownNCT03640728
- The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate CapsulesCompletedNCT03638076Phase 2
- Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.CompletedNCT03627507Phase 2/3
- Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001Status unknownNCT03625934Phase 2
- Mutations of the Pre-core Region of Hepatite B Virus (HBV)CompletedNCT03625258
- Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver CirrhosisCompletedNCT03620474Phase 1/2
- Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty LiverStatus unknownNCT03604016Phase 4
- Tenofovir Combination or Mono-therapy for MDR CHBStatus unknownNCT03597633
- A Study in Healthy VolunteersCompletedNCT03596697Phase 1
- Study on Gut Microbiota in Chronic HBV Infected PatientsStatus unknownNCT03587467
- APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis BCompletedNCT03585322Phase 1
- Simplified Antiviral Treatment Strategy for Hepatitis C in MyanmarCompletedNCT03579576
- Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative TreatmentCompletedNCT03577938Not applicable
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnNCT03575208Phase 2
- A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding BiomarkersStatus unknownNCT03568578Not applicable
- Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral ResistanceStatus unknownNCT03566030
- Treatment Efficacy and Safety of TDF-TAF Switch Study in South KoreaStatus unknownNCT03559790
- The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT03546530Not applicable
- Observational Study on Pregnant Women With Chronic Hepatitis B and Their InfantsStatus unknownNCT03539016
- Characterisation of Human B Cell Maturation in Response to VaccinationCompletedNCT03535779
- Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With LeukemiaStatus unknownNCT03529760
- The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With IbrutinibCompletedNCT03528941
- HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102Status unknownNCT03519113Phase 2/3
- Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell TransplantCompletedNCT03511794
- Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral InfectionsStatus unknownNCT03495570
- Entecavir to TAF SwitchActive, not recruitingNCT03489239Phase 3
- Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B PatientsCompletedNCT03485534Phase 4
- Crowdsourcing to Promote HBV and HCV Testing in ChinaCompletedNCT03482388Not applicable
- Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical TransmissionStatus unknownNCT03476083Phase 4
- Drug Drug Interaction Study for EYP001 With EntecavirCompletedNCT03469583Phase 1
- The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After DiscontinuationCompletedNCT03468907Phase 4
- A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically SuppressedCompletedNCT03463369Phase 1
- Cohort Study on People Who Inject Drugs in SenegalStatus unknownNCT03459768
- Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.CompletedNCT03459521Not applicable
- Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced PatientsStatus unknownNCT03448744Phase 4
- A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis BCompletedNCT03439488Phase 1
- Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced CirrhosisStatus unknownNCT03437876Not applicable
- Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western ChinaStatus unknownNCT03435406
- Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis BStatus unknownNCT03429439Not applicable
- A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis BCompletedNCT03426618
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfectionStatus unknownNCT03425994
- Hepatitis B Virus Prevalence and Risk Factors in BelgiumCompletedNCT03425513
- Hepatitis B Vaccine for Non-respondersCompletedNCT03415672Phase 2
- HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAgStatus unknownNCT03405597Phase 3
- Hepatitis B Prevalence in the Turkish Population Living in Middle LimburgStatus unknownNCT03396458
- Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral TherapyStatus unknownNCT03366571
- Epidemiology of Hepatitis B, C and Delta in Reunion IslandStatus unknownNCT03362866
- A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study)Status unknownNCT03358108
- A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis BStatus unknownNCT03357822Phase 4
- Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDFCompletedNCT03356834Phase 4
- HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue TherapyCompletedNCT03350074
- Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownNCT03349008Phase 4
- Entecavir for Decompensated HBV CirrhosisCompletedNCT03345498
- Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B InfectionActive, not recruitingNCT03343431Phase 3
- Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in PakistanStatus unknownNCT03341195Not applicable
- Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B PatientsStatus unknownNCT03332329Phase 4
- Quality of Life and Health Utility of Patients With CHB InfectionsCompletedNCT03329820
- EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT03320616Phase 1
- The Effect of Entecavir Consolidation on Post-TDF Treatment DurabilityStatus unknownNCT03308890Phase 4
- ID HBV Vaccination With Imiquimod in OBICompletedNCT03307902Phase 2/3
- Biologic Basis of Liver Cancer From Chronic Hepatitis BCompletedNCT03300414
- Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B PatientCompletedNCT03294798Phase 1/2
- A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy ParticipantsCompletedNCT03285620Phase 1
- Evaluation of the Safety and Pharmacology of EYP001 in HBV SubjectsCompletedNCT03272009Phase 1
- The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by ResectionStatus unknownNCT03253250Phase 4
- Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C InfectionCompletedNCT03248622
- A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B PatientsStatus unknownNCT03244085Phase 1